| Human |
hsa_circ_SOD2 |
- |
hsa_circRNA_004662 |
Crohn disease |
SOD2 |
hsa-miR-4520-2-3p, hsa-miR-208b-5p, hsa-miR-4713-5p, hsa-miR-4659a-3p, hsa-miR-4659b-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_SOD2 |
hsa_circ_0004662 |
circSOD2 |
hepatocellular carcinoma |
SOD2 |
miR-502-5p |
Q
| UP |
More |
| Human |
hsa_circ_SOD2 |
- |
circSOD2 |
vascular disorder |
SOD2 |
miR-206, miR-150-5p, miR-15a-5p |
Q
S
| UP |
More |
| Human |
hsa_circ_SOD2 |
hsa_circ_0004662 |
circRNA superoxide dismutase 2 |
hepatocellular carcinoma |
SOD2 |
miR-497-5p |
Q
S
| UP |
More |
| Human |
hsa_circ_SOD2 |
hsa_circ_0004662 |
circSOD2 |
gastric cancer |
SOD2 |
miR-1296 |
Q
| UP |
More |
| Human |
hsa_circ_SOD2 |
hsa_circ_0004662 |
CircSOD2 |
ulcerative colitis |
SOD2 |
miR-378g |
Q
| UP |
More |
| Human |
hsa_circ_SOD2 |
hsa_circ_0004662 |
circ_0004662 |
osteoarthritis |
SOD2 |
miR-450b-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_SOD2 |
- |
circSOD2 |
clear cell renal carcinoma |
SOD2 |
- |
Q
S
M
| UP |
More |
| Human |
hsa_circ_SOD2 |
- |
circSOD2 |
renal cell carcinoma |
SOD2 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SOD2 |
- |
circRNA SOD2 / CircSOD2 |
non-small cell lung carcinoma |
SOD2 |
miR-2355-5p |
Q
| UP |
More |
| Human |
hsa_circ_SOD2 |
hsa_circ_0004662 |
circSOD2 / circ_0004662 |
osteoarthritis |
SOD2 |
miR-224-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_SOD2 |
- |
circSOD2 |
tuberculosis |
SOD2 |
miR-4519 |
Q
S
| UP |
More |
| Human |
hsa_circ_SOD2 |
hsa_circ_0004662 |
circSOD2 / circular RNA SOD2 |
metabolic dysfunction-associated steatotic liver disease |
SOD2 |
miR-532-3p |
Q
B
| UP |
More |
| Human |
hsa_circ_SOD2 |
hsa_circ_0004662 |
circSOD2 / hsa_circRNA_004662 |
clear cell renal carcinoma |
SOD2 |
miR-532-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_SOD2 |
hsa_circ_0004662 |
circ_0004662 |
colorectal cancer |
SOD2 |
- |
Q
| UP |
More |
| Human |
hsa_circ_SOD2 |
hsa_circ_0004662 |
circSOD2 |
metabolic dysfunction-associated steatotic liver disease |
SOD2 |
miR-29b |
Q
S
M
| UP |
More |